Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Diabetes Mellitus × pembrolizumab × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 12 Melanoma 10 Lung Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Neoplasms 5 Head and Neck Neoplasms 3 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Biliary Tract Neoplasms 2 Urinary Bladder Neoplasms 1 Uncommon Pathological Types of Lung Cancer 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Skin Neoplasms 1 Sexual Dysfunction, Physiological 1 Sarcopenia 1 Prostatic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms, Squamous Cell 1 Neoplasm Metastasis 1 NSCLC 1 Motor Activity 1 Lung Squamous Cell Carcinoma Stage IV 1 Lung Diseases, Interstitial 1 Liver Diseases 1 Kidney Neoplasms 1

Interventions

Surveys and Questionnaires 2 Specimen Handling 2 Pioglitazone 2 Glucose Tolerance Test 2 pembrolizumab 1 nabiximols 1 Urine Specimen Collection 1 Testosterone 1 Standard of Care 1 Phlebotomy 1 Liquid Biopsy 1 Interviews as Topic 1 Hypoglycemic Agents 1 Gonadotropin-Releasing Hormone 1 Gastrectomy 1 Endoscopic Mucosal Resection 1 Electrocardiography 1 Eating 1 DNA 1 Clinical Laboratory Techniques 1 Cari-D-Tect 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06100796 2023-10-25

NSCLC

Assiut University

Diabetes Mellitus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡